| Trial ID: | L1537 |
| Source ID: | NCT00563446
|
| Associated Drug: |
Darbepoetin Alfa
|
| Title: |
Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia|Kidney Failure, Chronic|Peritoneal Dialysis, Continuous Ambulatory
|
| Interventions: |
DRUG: Darbepoetin alfa
|
| Outcome Measures: |
Primary: Hemoglobin level, Over 6 months |
|
| Sponsor/Collaborators: |
Sponsor: Hospital Authority, Hong Kong | Collaborators: Kirin Pharmaceutical (Asia) CO., LTD
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-07
|
| Completion Date: |
2006-05
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-16
|
| Locations: |
Princess Margaret Hospital, Hong Kong, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00563446
|
